Loading provider…
Loading provider…
Internal Medicine Physician in New York, NY
NPI: 1538327457Primary Employer
Memorial Sloan Kettering Cancer Center
mskcc.org
HQ Phone
Get M.D. Anna's Phone Numberphone_androidMobile
Get M.D. Anna's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
FL State Medical License
2021
NJ State Medical License
2009 - 2027
CT State Medical License
2023 - 2025
NY State Medical License
2010 - 2025
NH State Medical License
2024 - 2024
NC State Medical License
2020 - 2022
MA State Medical License
2009 - 2011

American Board of Internal Medicine
Medical Oncology
Cleveland Medical College, Homeopathic
case.edu
Medical School
Until 2006
Memorial Sloan Kettering Cancer Center
Fellowship • Hematology and Medical Oncology
2010 - 2013
Beth Israel Deaconess Medical Center
Residency • Internal Medicine
2006 - 2009
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 76 | 191 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 62 | 62 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 61 | 146 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 56 | 108 |
| 5 | 99212Established patient outpatient visit, total time 10-19 minutes | 34 | 56 |
Incidence, Management, and Implications of Visceral Thrombosis in Pancreatic Ductal Adenocarcinoma.
Authors: Eileen O'Reilly, Kenneth Yu, Angel Mier Hicks, Maeve Lowery
Journal: Clin Colorectal Cancer
Publication Date: 2018-01-31
RNA neoantigen vaccines prime long-lived CD8T cells in pancreatic cancer.
Authors: Avni Desai, Olca Basturk, Andrew Epstein, Jeffrey Drebin, T Kingham, Kevin Soares, William Jarnagin, Alice Wei, Vinod Balachandran, Jedd Wolchok, Parisa Momtaz
Publication Date: 2025-03
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, PROCEDURE: Resection, DRUG: Fluorouracil, DRUG: Oxaliplatin, DRUG: Irinotecan Hydrochloride, DRUG: Leucovorin Calcium
Lead Sponsor: Silenseed Ltd
Intervention / Treatment: DRUG: siG12D-LODER, DRUG: Gemcitabine+nab-Paclitaxel, DRUG: Folfirinox
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Abemaciclib, DRUG: Cisplatin, DRUG: Midazolam, DRUG: Fulvestrant, DRUG: Letrozole, DRUG: LY3023414, DRUG: Pemetrexed